Andrea Wang-Gillam
Director, Developmental Therapeutics Program · University of Pennsylvania Health System
Credentials: · · · ·
History
PresentGastrointestinal Oncology Program · University of Pennsylvania Health System
- 2004–2006
Medical Oncology
- 2001–2004
Internal Medicine
1997–2001
Research
Cancer Research · 2014 · 1,113 citations
The Lancet · 2016 · First of 22 authors · 970 citations
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Nature Medicine · 2016 · 857 citations
- KL
25 papers
- BT
24 papers
23 papers
- RS
18 papers
16 papers
16 papers
- KP
11 papers · 1 as a fellow
- JP
10 papers
Grants
- 2014–2023
National Cancer Institute · UM1
PI · $6.1M · Duke University
- 2016–2022
Washington University SPORE in Pancreatic Cancer
National Cancer Institute · P50
Project lead · $1.2M · Washington University
- 2017–2019
Washington University PDX Development and Trial Center
National Cancer Institute · U54
Project lead · $695.6K · Washington University
Clinical trials
- 2015–2018
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Principal investigator · Terminated · Phase 1, Phase 2
Washington University School of Medicine
- 2013–2017
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
Principal investigator · Completed · Phase 1
Washington University School of Medicine
- 2012–2016
Principal investigator · Completed · Phase 1
Washington University School of Medicine
- 2009–2014
Erlotinib and Temsirolimus for Solid Tumors
Principal investigator · Completed · Phase 1
Washington University School of Medicine